Indexes of NO bioavailability in human blood

被引：51

作者：

Lauer, T ^{[1
]}

Kleinbongard, P ^{[1
]}

Kelm, M ^{[1
]}

机构：

[1] Univ Dusseldorf, Klin Kardiol Pneumol & Angiol, D-40225 Dusseldorf, Germany

来源：

NEWS IN PHYSIOLOGICAL SCIENCES | 2002年 / 17卷

关键词：

D O I：

10.1152/nips.01405.2002

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Disturbances of nitric oxide (NO) bioavailability may play a key role in vascular dysfunction and in the development of atherosclerotic lesions. Thus assessment of a reduced NO bioavailability in human circulation is of particular interest. Here we summarize potential biomarkers of NO availability in human blood and critically discuss their respective significance and application fields.

引用

页码：251 / 255

页数：5

共 15 条

[1] Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].

Böger, RH ;

Bode-Böger, SM ;

Szuba, A ;

Tsao, PS ;

Chan, JR ;

Tangphao, O ;

Blaschke, TF ;

Cooke, JP .

CIRCULATION, 1998, 98 (18) :1842-1847

[2] Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization [J].

Boucher, JL ;

Moali, C ;

Tenu, JP .

CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (8-9) :1015-1028

[3] Effects of inhaled oxide on regional blood flow are consistent with intravascular nitric oxide delivery [J].

Cannon, RO ;

Schechter, AN ;

Panza, JA ;

Ognibene, FP ;

Pease-Fye, ME ;

Waclawiw, MA ;

Shelhamer, JH ;

Gladwin, MT .

JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :279-287

[4] Decreased plasma concentrations of L-hydroxyarginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors [J].

Garlichs, CD ;

Beyer, J ;

Zhang, H ;

Schmeisser, A ;

Plötze, K ;

Mügge, A ;

Schellong, S ;

Daniel, WG .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 135 (05) :419-425

[5] Relative role of heme nitrosylation and β-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation [J].

Gladwin, MT ;

Ognibene, FP ;

Pannell, LK ;

Nichols, JS ;

Pease-Fye, ME ;

Shelhamer, JH ;

Schechter, AN .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :9943-9948

[6] Nitric oxide metabolism and breakdown [J].

Kelm, M .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :273-289

[7] Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action [J].

Lauer, T ;

Preik, M ;

Rassaf, T ;

Strauer, BE ;

Deussen, A ;

Feelisch, M ;

Kelm, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12814-12819

[8] Endogenous nitric oxide synthase inhibitor - A novel marker of atherosclerosis [J].

Miyazaki, H ;

Matsuoka, H ;

Cooke, JP ;

Usui, M ;

Ueda, S ;

Okuda, S ;

Imaizumi, T .

CIRCULATION, 1999, 99 (09) :1141-1146

[9] MOLECULAR MECHANISMS AND THERAPEUTIC STRATEGIES RELATED TO NITRIC-OXIDE [J].

MONCADA, S ;

HIGGS, EA .

FASEB JOURNAL, 1995, 9 (13) :1319-1330

[10] NITRIC-OXIDE CIRCULATES IN MAMMALIAN PLASMA PRIMARILY AS AN S-NITROSO ADDUCT OF SERUM-ALBUMIN [J].

STAMLER, JS ;

JARAKI, O ;

OSBORNE, J ;

SIMON, DI ;

KEANEY, J ;

VITA, J ;

SINGEL, D ;

VALERI, CR ;

LOSCALZO, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7674-7677

← 1 2 →